Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Your Article Summary
See Latest ArticlesEscitalopram in the Treatment of Adolescent Depression: A Randomized Placebo-Controlled Multisite Trial
Journal of the American Academy of Child and Adolescent Psychiatry, 05/27/09
Emslie GJ et al. - Escitalopram was effective and well tolerated in the treatment of depressed adolescents.
Methods- Male and female adolescents (aged 12-17 years) with DSM-IV-defined major depressive disorder were randomly assigned to 8 weeks of double-blind treatment with escitalopram 10 to 20 mg/day (n = 155) or placebo (n = 157).
- The primary efficacy parameter was change from baseline to week 8 in Children's Depression Rating Scale-Revised (CDRS-R) score using the last observation carried forward approach.
- A total of 83% patients (259/312) completed 8 weeks of double-blind treatment.
- Mean CDRS-R score at baseline was 57.6 for escitalopram and 56.0 for placebo.
- Significant improvement was seen in the escitalopram group relative to the placebo group at endpoint in CDRS-R score (-22.1 versus -18.8, p =.022; last observation carried forward).
- Adverse events occurring in at least 10% of escitalopram patients were headache, menstrual cramps, insomnia, and nausea; only influenza-like symptoms occurred in at least 5% of escitalopram patients and at least twice the incidence of placebo (7.1% versus 3.2%).
- Discontinuation rates due to adverse events were 2.6% for escitalopram and 0.6% for placebo.
- Serious adverse events were reported by 2.6% and 1.3% of escitalopram and placebo patients, respectively, and incidence of suicidality was similar for both groups.
Related Articles
Treating depression in teens has lasting benefits
Reuters, 11/04/09
Relevance Score: 69%
A systematic review of longitudinal studies on the association between depression and smoking in adolescents
BMC Public Health, 10/01/09
Relevance Score: 69%
Depression and Language Acculturation Correlate With Smoking Among Older Asian American Adolescents in New York City
Public Health Nursing, 11/10/09
Relevance Score: 68%
Initial psychometric properties of the Inventory of Functional Status after Childbirth - Revised for Adolescents
Journal of Reproductive and Infant Psychology, 10/26/09
Relevance Score: 68%
Prevention of depression and anxiety in adolescents: A randomized controlled trial testing the efficacy and mechanisms of Internet-based self-help problem-solving therapy
Trials, 10/14/09
Relevance Score: 68%
Today in Adolescent Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Time From First Intercourse to First Sexually Transmitted Infection Diagnosis Among Adolescent Women
Archives of Pediatrics and Adolescent Medicine, 12/09/09
Health-Related Quality of Life in Adolescents and Young Adults with a History of Kawasaki Disease
The Journal of Pediatrics, 12/08/09
Measuring Alcohol-Related Consequences in School Surveys: Alcohol-Attributable Consequences or Consequences With Students’ Alcohol Attribution
American Journal of Epidemiology, 12/08/09
Today in Mental Health...keeping you current
Receive free subspecialty "5-minute updates" via email
Anorexia Nervosa
FOCUS (The Journal of Lifelong Learning in Psychiatry), 12/09/09
Update on the management of attention-deficit/hyperactivity disorder in children and adults: patient onsiderations and the role of lisdexamfetamine
Therapeutics and Clinical Risk Management, 12/09/09
The association between obesity and anxiety disorders in the population: a systematic review and meta-analysis
International Journal of Obesity, 12/09/09
Sponsor
Article Search
Sponsor
Sponsor